Pharma BD Deal Intelligence
Ranks computed across 828 graded deals (Critic + Outcome Score both present).
Pfizer increases offer for AstraZeneca to approximately $118 billion. AstraZeneca board ultimately rejects the final proposal stating Pfizer has failed to make…
Source summaries from our enrichment pipeline; follow links for originals.
All 4 sources with sentiment breakdown →
Pfizer made an unsolicited bid to acquire AstraZeneca for approximately $118 billion, which would have been the largest pharmaceutical deal in history. AstraZeneca's board rejected the bid, and Pfizer ultimately withdrew after UK takeover rules prevented a further approach for six months.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Pfizer Inc. / AstraZeneca PLC (this deal) | 2014 | $118.0B | 27 |
| Pfizer Inc. / BioNTech SE | 2020 | $748M | 100 |
| Pfizer Inc. / FoldRx Pharmaceuticals | 2010 | — | 99 |
| Pfizer Inc. / Medivation Inc. | 2016 | $14.0B | 86 |
| Pfizer Inc. / Wyeth | 2009 | $68.0B | 86 |
| Pfizer Inc. / Warner-Lambert Company | 2000 | $90.0B | 83 |
| Pfizer Inc. / Arvinas, Inc. | 2021 | $2.4B | 77 |
← Browse all deals · How we score deals
More: 2014 deals · Pfizer Inc. deals · Cardiovascular deals